Treatment | YST | Structural heterogeneity (SCIDBH) | Growth variation (SCIΔBA) | ||
---|---|---|---|---|---|
1–3 | 8–10 | 1–3 | 8–10 | ||
Control |  | 5.81 ± 0.08 (5.20–6.40) | 5.58 ± 0.07 (5.20–6.13) | 4.51 ± 0.17 (3.44–5.85) | 4.94 ± 0.19 (3.32–6.45) |
33% Crown |  | 4.20 ± 0.19 (3.21–5.69) | 4.18 ± 0.21 (2.91–5.68) | 4.50 ± 0.35 (2.24–7.93) | 5.22 ± 0.34 (2.75–7.67) |
33% Dominant |  | 3.47 ± 0.21 (1.99–4.89) | 3.37 ± 0.31 (1.78–5.56) | 3.81 ± 0.28 (2.56–7.45) | 4.86 ± 0.51 (2.47–8.95) |
33% Low |  | 3.07 ± 0.15 (2.24–4.25) | 3.42 ± 0.16 (2.59–4.73) | 4.25 ± 0.24 (2.39–6.04) | 5.26 ± 0.36 (2.55–7.47) |
50% Crown |  | 4.26 ± 0.17 (2.88–5.41) | 3.91 ± 0.24 (2.85–5.87) | 4.79 ± 0.33 (2.75–7.81) | 5.30 ± 0.38 (2.75–8.28) |
50% Dominant |  | 2.76 ± 0.15 (1.94–3.68) | 2.49 ± 0.23 (1.58–4.03) | 3.82 ± 0.40 (1.72–7.83) | 4.73 ± 0.63 (1.65–9.97) |
50% Low |  | 2.46 ± 0.07 (1.98–2.97) | 2.53 ± 0.10 (2.19–3.47) | 4.15 ± 0.24 (2.65–6.17) | 4.78 ± 0.31 (3.18–7.45) |